Examining how mothers pass COVID-19 antibodies to their infants
Children's Hospital of Chongqing Medical University
Children's Hospital of Chongqing Medical University · NCT05851911
This study looks at how mothers pass COVID-19 antibodies to their babies under 2 years old to see if it helps protect them from getting sick.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 0 Months to 2 Years |
| Sex | All |
| Sponsor | Children's Hospital of Chongqing Medical University (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Chongqing, Chongqing) |
| Trial ID | NCT05851911 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the transmission of COVID-19 antibodies from mothers to their infants, focusing on children aged 0-2. By monitoring the specific antibodies present in young children, the study aims to understand the effectiveness of maternal passive immunity and its implications for children's risk of COVID-19 infection. The findings will contribute to developing immune prevention strategies for this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 0-2 who have not undergone blood transfusions or immunosuppressive therapies.
Not a fit: Patients who may not benefit from this study include those with a history of blood transfusions, chemotherapy, or immune system-related diseases.
Why it matters
Potential benefit: If successful, this study could enhance understanding of maternal immunity and improve strategies for protecting infants from COVID-19.
How similar studies have performed: While there is limited research specifically on maternal transmission of COVID-19 antibodies, similar studies on maternal antibody transfer for other infections have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Children aged 0-2; 2. No history of blood transfusion, chemotherapy, or related immunosuppressive therapy; No immune system related diseases; Exclusion Criteria: Not willing to participate
Where this trial is running
Chongqing, Chongqing
- Yuting Yang — Chongqing, Chongqing, China (RECRUITING)
Study contacts
- Study coordinator: Yuting Yang, Ms
- Email: 412384223@qq.com
- Phone: 18990304808
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Passive Transmission of Maternal and Infant Antibodies